Synthesis of New Thiazole Clubbed Imidazo[2,1-b]thiazole Hybrid as
Antimycobacterial Agents

Huda   K.   Mahmoud; Abdelwahed   R.   Sayed; Marwa   M.   Abdel-Aziz; Sobhi   M.   Gomha

doi:10.2174/1573406418666220413095854

Abstract

Aims: The study aims to synthesize bioactive hybrid pharmacophores (thiazole ring and imidazo[2,1-b]thiazole system) by incorporating them into one biological assessment molecular system.

Background: A literature survey revealed that various imidazo[2,1-b]thiazoles, thiazoles, and hydrazones have powerful antimycobacterial activity.

Objective: This study demonstrates the effectiveness of molecular hybridization and the scope for imidazo[2,1-b]thiazole-hydrazone-thiazoles to develop as promising antimycobacterial agents.

Methods: Several imidazo[2,1-b]thiazole–hydrazine-thiazoles 5a-g, 7a,b, 9a,b, 11a,b, 13, and 15a,b were generated using a molecular hybridization strategy and assessed against Mycobacterium tuberculosis (ATCC 25618) for their in vitro antituberculous activity.

Results: Derivative 7b (MIC = 0.98 μg/mL) has shown the most promising antimycobacterial activity among the series tested. Brief structure-activity relationship studies found that the thiazole of chlorophenyl or pyridine, or coumarin had a significant relation with the antimycobacterial activity.

Conclusion: The promising antimycobacterial activity of compound 7b compared with the reference drug suggests that this compound may contribute as a lead compound in the search for new potential antimycobacterial agents.

Keywords: Thiosemicarbazones, imidazothiazole, thiazole, hydrazones, bis-heterocycles, tuberculosis.

« Previous Next »

Graphical Abstract

[1] 
 Tuberculosis; World Health Organization: Geneva. 2014. Available from: http://www.who.int/tb/research/en/
[2] 
Singh, M.M. XDR-TB-danger ahead. Indian J. Tuberc.,  2007, 54(1), 1-2.
[http://dx.doi.org/10.1016/j.ijtb.2021.06.008] [PMID:  17455416] 
[3] 
Remers, W.A. Antineoplastic Agents. In: Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry; 10th ed; Delgado, J.N.; Remers, W.A., Eds.; Lippincott-Raven: Philadelphia, 1998; p. 391.
[4] 
Andreani, A.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M. Synthesis and antitubercular activity of imidazo[2,1-b]thiazoles. Eur. J. Med. Chem.,  2001, 36(9), 743-746.
[http://dx.doi.org/10.1016/S0223-5234(01)01266-1] [PMID:  11672884] 
[5] 
Cesur, Z.; Güner, H.; Ötük, G. Synthesis and antimycobacterial activity of new imidazo[2,1-b]thiazole derivatives. Eur. J. Med. Chem.,  1994, 29(12), 981-983.
[http://dx.doi.org/10.1016/0223-5234(94)90199-6] 
[6] 
Ulusoy Güzeldemirci, N.; Karaman, B.; Küçükbasmaci, Ö. Antibacterial, antitubercular and antiviral activity evaluations of some aryli-denehydrazide derivatives bearing imidazo[2,1-b]thiazole moiety. Turk. J. Pharm. Sci.,  2017, 14(2), 157-163.
[http://dx.doi.org/10.4274/tjps.25743] [PMID:  32454607] 
[7] 
Park, J.H.; El-Gamal, M.I.; Lee, Y.S.; Oh, C.H. New imidazo[2,1-b]thiazole derivatives: Synthesis, in vitro anticancer evaluation, and in silico studies. Eur. J. Med. Chem.,  2011, 46(12), 5769-5777.
[http://dx.doi.org/10.1016/j.ejmech.2011.08.024] [PMID:  22033063] 
[8] 
Budriesi, R.; Ioan, P.; Locatelli, A.; Cosconati, S.; Leoni, A.; Ugenti, M.P.; Andreani, A.; Di Toro, R.; Bedini, A.; Spampinato, S.; Marinelli, L.; Novellino, E.; Chiarini, A. Imidazo[2,1-b]thiazole system: A scaffold endowing dihydropyridines with selective cardiodepressant ac-tivity. J. Med. Chem.,  2008, 51(6), 1592-1600.
[http://dx.doi.org/10.1021/jm070681+] [PMID:  18303827] 
[9] 
Shetty, N.S.; Khazi, I.A.M.; Ahn, C. Synthesis, anthelmintic and anti-inflammator y activities of some novel imidazothiazole sulfides and sulfones. Bull. Korean Chem. Soc.,  2010, 31(8), 2337-2340.
[http://dx.doi.org/10.5012/bkcs.2010.31.8.2337] 
[10] 
Villemagne, B.; Flipo, M.; Blondiaux, N.; Crauste, C.; Malaquin, S.; Leroux, F.; Piveteau, C.; Villeret, V.; Brodin, P.; Villoutreix, B.O.; Sperandio, O.; Soror, S.H.; Wohlkönig, A.; Wintjens, R.; Deprez, B.; Baulard, A.R.; Willand, N. Ligand efficiency driven design of new in-hibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches. J. Med. Chem.,  2014, 57(11), 4876-4888.
[http://dx.doi.org/10.1021/jm500422b] [PMID:  24818704] 
[11] 
Meissner, A.; Boshoff, H.I.; Vasan, M.; Duckworth, B.P.; Barry, C.E., III; Aldrich, C.C. Structure-activity relationships of 2-aminothiazoles effective against Mycobacterium tuberculosis. Bioorg. Med. Chem.,  2013, 21(21), 6385-6397.
[http://dx.doi.org/10.1016/j.bmc.2013.08.048] [PMID:  24075144] 
[12] 
Shaikh, M.S.; Palkar, M.B.; Patel, H.M.; Rane, R.A.; Alwan, W.S.; Shaikh, M.M.; Shaikh, I.M.; Hampannavar, G.A.; Karpoormath, R. De-sign and synthesis of novel carbazolo–thiazoles as potential anti-mycobacterial agents using a molecular hybridization approach. RSC Advances,  2014, 4(107), 410762308-6232010.
[http://dx.doi.org/10.1039/C4RA11752B] 
[13] 
Rangaraju, A.; Pannerselvam, P.; Murali, K. Synthesis of novel 1H-indole-2,3-dione derivatives as potent antimycobacterial agents. Int. J. Adv. Pharm. Biol.Chem.,  2013, 2, 616-622.
[14] 
Mundhe, D.; Chandewar, A.V.; Shiradkar, M.R. Design and synthesis of substituted clubbed triazolyl thiazole as XDR & MDR antituber-culosis agents Part-II. Pharma Chem.,  2011, 3, 89-102.
[15] 
Nagesh, H.N.; Suresh, A.; Sairam, S.D.; Sriram, D.; Yogeeswari, P.; Chandra Sekhar, K.V. Design, synthesis and antimycobacterial evalua-tion of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues. Eur. J. Med. Chem.,  2014, 84, 605-613.
[http://dx.doi.org/10.1016/j.ejmech.2014.07.067] [PMID:  25062011] 
[16] 
Mamolo, M.G.; Falagiani, V.; Zampieri, D.; Vio, L.; Banfi, E.; Scialino, G. Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives. Farmaco,  2003, 58(9), 631-637.
[http://dx.doi.org/10.1016/S0014-827X(03)00103-4] [PMID:  13679155] 
[17] 
Aridoss, G.; Amirthaganesan, S.; Kim, M.S.; Kim, J.T.; Jeong, Y.T. Synthesis, spectral and biological evaluation of some new thiazoli-dinones and thiazoles based on t-3-alkyl-r-2,c-6-diarylpiperidin-4-ones. Eur. J. Med. Chem.,  2009, 44(10), 4199-4210.
[http://dx.doi.org/10.1016/j.ejmech.2009.05.015] [PMID:  19535178] 
[18] 
Makam, P.; Kankanala, R.; Prakash, A.; Kannan, T. 2-(2-Hydrazinyl)thiazole derivatives: Design, synthesis and in vitro antimycobacterial studies. Eur. J. Med. Chem.,  2013, 69, 564-576.
[http://dx.doi.org/10.1016/j.ejmech.2013.08.054] [PMID:  24095750] 
[19] 
Sah, P.P.T.; Peoples, S.A. Isonicotinyl hydrazones as antitubercular agents and derivatives for identification of aldehydes and ketones. J. Am. Pharm. Assoc. (Sci. Ed),  1954, 43(9), 513-524.
[http://dx.doi.org/10.1002/jps.3030430902] [PMID:  13201471] 
[20] 
Mathew, B.; Suresh, J.; Ahsan, M.J.; Mathew, G.E.; Usman, D.; Subramanyan, P.N.S.; Safna, K.F.; Maddela, S. Hydrazones as a privileged structural linker in antitubercular agents: A review. Infect. Disord. Drug Targets,  2015, 15(2), 76-88.
[http://dx.doi.org/10.2174/1871526515666150724104411] [PMID:  26205803] 
[21] 
Bijev, A. New heterocyclic hydrazones in the search for antitubercular agents: Synthesis and in vitro evaluations. Lett. Drug Des. Discov.,  2006, 3(7), 506-512.
[http://dx.doi.org/10.2174/157018006778194790] 
[22] 
Thomas, K.D.; Adhikari, A.V.; Telkar, S.; Chowdhury, I.H.; Mahmood, R.; Pal, N.K.; Row, G.; Sumesh, E. Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents. Eur. J. Med. Chem.,  2011, 46(11), 5283-5292.
[http://dx.doi.org/10.1016/j.ejmech.2011.07.033] [PMID:  21907466] 
[23] 
Küçükgüzel, Ş.G.; Rollas, S.; Küçükgüzel, İ.; Kiraz, M. Synthesis and antimycobacterial activity of some coupling products from 4-aminobenzoic acid antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones. Eur. J. Med. Chem.,  1999, 34, 1093-1100.
[http://dx.doi.org/10.1016/S0223-5234(99)00129-4] 
[24] 
Abu-Melha, S.; Gomha, S.M.; Abouzied, A.S.; Edrees, M.M.; Abo Dena, A.S.; Muhammad, Z.A. Microwave-assisted one pot three-component synthesis of novel bioactive thiazolyl-pyridazinediones as potential antimicrobial agents against antibiotic-resistant bacteria. Molecules,  2021, 26(14), 4260.
[http://dx.doi.org/10.3390/molecules26144260] [PMID:  34299535] 
[25] 
Abu-Melha, S.; Muhammad, Z.A.; Abouzid, A.S.; Edrees, M.M.; Abo Dena, A.S.; Nabil, S.; Gomha, S.M. Multicomponent synthesis, DFT calculations and molecular docking studies of novel thiazolyl-pyridazinones as potential antimicrobial agents against antibiotic-resistant bacteria. J. Mol. Struct.,  2021, 1234, 130180.
[http://dx.doi.org/10.1016/j.molstruc.2021.130180] 
[26] 
Alshabanah, L.A.; Gomha, S.M.; Al-Mutabagani, L.A.; Abolibda, T.Z.; Abd El-Ghany, N.A.; El-Enany, W.A.M.A.; El-Ziaty, A.K.; Ali, R.S.; Mohamed, N.A. Cross-linked chitosan/multi-walled carbon nanotubes composite as ecofriendly biocatalyst for synthesis of some composite as ecofriendly biocatalyst for synthesis of some novel benzil bis-thiazoles. Polymers (Basel),  2021, 13, 1728.
[http://dx.doi.org/10.3390/polym13111728] [PMID:  34070526] 
[27] 
Sayed, A.R.; Gomha, S.M. Abd El-lateef, H.M.; Abolibda, T.Z. L-Proline catalyzed green synthesis and anticancer evaluation of novel bioactive benzil bis-hydrazones under grinding technique. Green Chem. Lett. Rev.,  2021, 14(2), 179-188.
[http://dx.doi.org/10.1080/17518253.2021.1893392] 
[28] 
Abdelwahed, R.S.; Gomha, S.M.; Shalabi, K.; Abd El-Lateef, H. Synthesis and study of poly[(hydrazinylazo)]thiazoles as potent corro-sion inhibitors for cast iron-carbon alloy in molar HCl: A collective computational and experiential methods. J. Mol. Liq.,  2021, 337, 116555.
[http://dx.doi.org/10.1016/j.molliq.2021.116555] 
[29] 
Gomha, S.M.; Edrees, M.M.; Altalbawy, F.M.A. synthesis and characterization of some new bis-pyrazolyl-thiazoles incorporating the thiophene moiety as potent anti-tumor agents. Int. J. Mol. Sci.,  2016, 17(9), 1499.
[http://dx.doi.org/10.3390/ijms17091499] [PMID:  27618013] 
[30] 
Gomha, S.M.; Riyadh, S.M.; Abdalla, M.M. Solvent-drop grinding method: Efficient synthesis, DPPH radical scavenging and anti-diabetic activities of chalcones, bis-chalcones, azolines, and bis-azolines. Curr. Org. Synth.,  2015, 12(2), 220-228.
[http://dx.doi.org/10.2174/1570179412666150122230447] 
[31] 
Gomha, S.M.; Badrey, M.G.; Edrees, M.M. Heterocyclization of a bis-thiosemicarbazone of 2,5-diacetyl-3,4-disubstituted-thieno[2,3-b]thiophene bis-thiosemicarbazones leading to bis-thiazoles and bis-1,3,4-thiadiazoles as anti-breast cancer agents. J. Chem. Res.,  2016, 40, 120-125.
[http://dx.doi.org/10.3184/174751916X14537182696214] 
[32] 
Gomha, S.M.; Muhammad, Z.A.; El-Reedy, A.A.M. Intramolecular ring transformation of bis-oxadiazoles to bis-thiadiazoles and investi-gation of their anticancer activities. J. Heterocycl. Chem.,  2018, 55(10), 2360-2367.
[http://dx.doi.org/10.1002/jhet.3300] 
[33] 
Abdallah, M.A.; Riyadh, S.M.; Abbas, I.M.; Gomha, S.M. Synthesis and biological activities of 7-arylazo-7H-pyrazolo[5,1-c][1,2,4]triazolo-6(5H)-ones and 7-arylhydrazono-7H-[1,2,4] triazolo [3,4-b][1,3,4]thiadiazines. J. Chin. Chem. Soc. (Taipei),  2005, 52(5), 987-994.
[http://dx.doi.org/10.1002/jccs.200500137] 
[34] 
Abbas, I.M.; Riyadh, S.M.; Abdallah, M.A.; Gomha, S.M. A novel route to tetracyclic fused tetrazines and thiadiazines. J. Heterocycl. Chem.,  2006, 43(4), 935-942.
[http://dx.doi.org/10.1002/jhet.5570430419] 
[35] 
Gomha, S.M.; Riyadh, S.M.; Mahmmoud, E.A.; Elaasser, M.M. Synthesis and anticancer activities of thiazoles, 1,3-thiazines, and thiazol-idine using chitosan-grafted-poly (vinylpyridine) as basic catalyst. Heterocycles,  2015, 91, 1227.
[http://dx.doi.org/10.3987/COM-15-13210] 
[36] 
Gomha, S.M.; Edrees, M.M.; El-Arab, E.E. Synthesis and preliminary in-vitro cytotoxic evaluation of some novel bis-heterocycles incor-porating thienothiophene. J. Heterocycl. Chem.,  2017, 54(1), 641-647.
[http://dx.doi.org/10.1002/jhet.2636] 
[37] 
Gomha, S.M.; El-Hashash, M.A.; Edrees, M.M.; El-Arab, E.E. Synthesis, characterization and molecular docking of novel bis-thiazolyl thienothiophene derivatives as promising cytotoxic antitumor drug. J. Heterocycl. Chem.,  2017, 54(5), 2686-2695.
[http://dx.doi.org/10.1002/jhet.2869] 
[38] 
Abdelrazek, F.M.; Gomha, S.M.; Metz, P.; Abdalla, M.M. Synthesis of some novel 1,4-phenylene-bis-thiazolyl derivatives and their anti-hypertensive α-blocking activity screening. J. Heterocycl. Chem.,  2017, 54(1), 618-623.
[http://dx.doi.org/10.1002/jhet.2633] 
[39] 
Gomha, S.M.; Abbas, I.M.; Elaasser, M.M.; Mabrouk, B.K.A. Synthesis, molecular docking and pharmacological study of pyrimido-thiadiazinones and its bis-derivatives. Lett. Drug Des. Discov.,  2017, 14(4), 434-443.
[http://dx.doi.org/10.2174/1570180813666160815125409] 
[40] 
Gomha, S.M. A facile one-pot synthesis of 6,7,8,9-tetrahydrobenzo[4,5]thieno[2,3-d]- 1,2,4-triazolo[4,5-a]pyrimidin-5-ones. Monatsh. Chem.,  2009, 140(2), 213-220.
[http://dx.doi.org/10.1007/s00706-008-0060-z] 
[41] 
Vekariya, R.H.; Patel, K.D.; Vekariya, M.K.; Prajapati, N.P.; Rajani, D.P.; Rajani, S.D.; Patel, H.D. Microwave-assisted green synthesis of new imidazo[2,1-b]thiazole derivatives and their antimicrobial, antimalarial, and antitubercular activities. Res. Chem. Intermed.,  2017, 43(11), 1-25.
[http://dx.doi.org/10.1007/s11164-017-2985-5] 
[42] 
Franzblau, S.G.; Witzig, R.S.; McLaughlin, J.C.; Torres, P.; Madico, G.; Hernandez, A.; Degnan, M.T.; Cook, M.B.; Quenzer, V.K.; Fergu-son, R.M.; Gilman, R.H. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the micro-plate Alamar Blue assay. J. Clin. Microbiol.,  1998, 36(2), 362-366.
[http://dx.doi.org/10.1128/JCM.36.2.362-366.1998] [PMID:  9466742] 
[43] 
Collins, L.; Franzblau, S.G. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother.,  1997, 41(5), 1004-1009.
[http://dx.doi.org/10.1128/AAC.41.5.1004] [PMID:  9145860] 

Rights & Permissions Print Cite

Article Metrics

41

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1573406418666220413095854	Print ISSN 1573-4064
Publisher Name Bentham Science Publisher	Online ISSN 1875-6638

Medicinal Chemistry

Synthesis of New Thiazole Clubbed Imidazo[2,1-b]thiazole Hybrid as Antimycobacterial Agents

Abstract

Graphical Abstract

Related Journals

Related Books

Related Articles